Healthcare -
Medical - Devices - NASDAQ - US
$ 95.18
1.27 %
$ 3.22 B
Market Cap
87.27
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
TransMedics Group, Inc.
| Revenue | 442 M |
| Cost Of Revenue | 179 M |
| Gross Profit | 262 M |
| Operating Expenses | 225 M |
| Operating Income | 37.5 M |
| Other Expenses | 2.03 M |
| Net Income | 35.5 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 441.5 | 241.6 | 93.5 | 30.3 | 25.6 | 23.6 | 13.0 | 7.7 | 6.2 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 179.5 | 87.5 | 28.2 | 9.1 | 9.0 | 9.7 | 7.3 | 5.5 | 5.4 |
| Gross Profit | 262.1 | 154.1 | 65.3 | 21.2 | 16.6 | 13.9 | 5.7 | 2.1 | 0.8 |
| OPERATING INCOME | |||||||||
| Operating Expenses | 224.6 | 182.8 | 96.7 | 60.6 | 43.0 | 43.5 | 26.0 | 22.6 | 23.8 |
| Selling, General and Administrative Expenses | 168.6 | 119.6 | 69.9 | 38.3 | 24.2 | 23.6 | 12.3 | 7.6 | 8.1 |
| Research and Development Expenses | 56.0 | 63.3 | 26.8 | 22.3 | 18.8 | 19.9 | 13.7 | 15.0 | 15.6 |
| Operating Income | 37.5 | (28.7) | (31.4) | (39.4) | (26.4) | (29.6) | (20.2) | (20.4) | (23.0) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 14.4 | 10.8 | 3.7 | 3.9 | 4.0 | 4.4 | 2.4 | 1.1 | 1.0 |
| Total Other Income | (1.7) | 2.1 | (4.7) | (4.8) | (2.3) | (3.9) | (3.5) | (0.4) | (1.1) |
| Pre-Tax Income | 35.8 | (26.7) | (36.2) | (44.2) | (28.7) | (33.5) | (23.7) | (20.8) | (24.1) |
| NET INCOME | |||||||||
| Tax Provision | 0.3 | (1.6) | 66 K | 36 K | 32 K | 40 K | 41 K | 32 K | 1.0 |
| Net Income | 35.5 | (25.0) | (36.2) | (44.2) | (28.7) | (33.5) | (23.8) | (20.8) | (24.1) |
| EPS | 1.07 | 0.77 | 1.23 | 1.6 | 1.16 | 2.36 | 1.23 | 1.44 | 1.66 |